Topic Archives: Opiant Pharmaceuticals (OPNT)

This is a pitch from Jason Stutman’s The Cutting Edge newsletter, his higher-end service from Angel Publishing (about $1,500/year), and what caught my eye was the headline promise that Harvard University is “calling for a 29,000% surge for one tiny company you’ve never heard of.” So what is it? Well, it’s appropriate that we’re looking […]

Comments

  • Avatar

    Radius ($RDUS) assinged PDUFA date of March 30, 2017 for Abaloparatide-SC. Recently reported strong cash position of $40...

  • Avatar

    Radius ($RDUS) up 10% today. No particular news that I can find. It was starting to do well technically - may just be te...

  • SoGiAm

    Radius $RDUS is primo…..really a top shelf company with great ideas and superior execution. People in this one should ...

  • DrKSSMDPhD

    I may look at entering CLCD here. I have a sneaking feeling they may become a category killer in migraine the way Radius...

  • Avatar

    Radius (RDUS) and abaloparatide may soon be the standard of care for women with osteoporosis. http://finance.yahoo.com/...

  • DrKSSMDPhD

    Radius $RDUS is primo.....really a top shelf company with great ideas and superior execution. People in this one should ...

  • Avatar

    Good news for Radius (RDUS) today. Long RDUS. http://finance.yahoo.com/news/journal-clinical-endocrinology-metabolism-p...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info